Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCIN | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | LOXL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | ZNF670-ZNF695 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NMT2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | TUFT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | FSTL3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | NUPL2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ANKRD63 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | EEF1AKMT1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
mRNA | GAPDHS | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |